posted on 2013-11-22, 00:00authored bySioban D. Harlow, Margery Gass, Janet E. Hall, Roger Lobo, Pauline Maki, Robert W. Rebar, Sherry Sherman, Patrick M. Sluss, Tobie J. de Villiers
Objective: The aim of this article is to summarize the recommended updates to the 2001 Stages of
Reproductive Aging Workshop (STRAW) criteria. The 2011 STRAW 10 reviewed advances in
understanding of the critical changes in hypothalamic-pituitary-ovarian function that occur before
and after the final menstrual period.
Methods: Scientists from five countries and multiple disciplines evaluated data from cohort studies
of midlife women and in the context of chronic illness and endocrine disorders on change in
menstrual, endocrine, and ovarian markers of reproductive aging including antimu¨ llerian hormone,
inhibin-B, follicle-stimulating hormone, and antral follicle count. Modifications were adopted
by consensus.
Results: STRAW 10 simplified bleeding criteria for the early and late menopausal transition,
recommended modifications to criteria for the late reproductive stage (Stage -3) and the early
postmenopause stage (Stage 1), provided information on the duration of the late transition
(Stage -1) and early postmenopause (Stage 1), and recommended application regardless ofwomen’s
age, ethnicity, body size, or lifestyle characteristics.
Conclusions: STRAW 10 provides a more comprehensive basis for assessing reproductive aging
in research and clinical contexts. Application of the STRAW 10 staging system should improve
comparability of studies of midlife women and facilitate clinical decision making. Nonetheless,
important knowledge gaps persist, and seven research priorities are identified.